SCHEMBL5283887

SCHEMBL5283887

Cc1ccc(C(=O)NC(=N)N(C)c2cccc(I)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SCN2A Q99250 2/20 0.56
HSD17B1 P14061 4/20 0.42
HSD17B2 P37059 4/20 0.42
ALDH1A1 P00352 5/20 0.39
NPC1 O15118 5/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CCR6 P51684 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
POLB P06746 1/20 0.36
MTOR P42345 1/20 0.36
KCNK3 O14649 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4628691 0.89 SCN2A (0.44) SCN2AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4629476 0.84 SCN2A (0.42) SCN2AALDH1A1NPC1RAB9AGAA
SCHEMBL4628493 0.82 MAPT (0.42) SCN2AHSD17B1HSD17B2ALDH1A1NPC1
SCHEMBL4628451 0.79 MEN1 (0.46) SCN2AHSD17B1HSD17B2ALDH1A1NPC1
SCHEMBL4629451 0.78 SMN1; SMN2 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2GAA
SCHEMBL4628586 0.78 NPC1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2GAA
SCHEMBL4627528 0.76 SMN1; SMN2 (0.43) SCN2AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4629253 0.72 KMT2A (0.44) SCN2AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4628458 0.71 USP2 (0.48) ALDH1A1SMN1; SMN2NPSR1
SCHEMBL2094143 0.69 SCN2A (0.51) SCN2AHSD17B1HSD17B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE WYETH CORP (US) 2007-12-19 EP claimed
US-7041702-B1 Pharmaceutically active compounds and methods of use SCION PHARMACEUTICALS, INC. (US) 2006-05-09 US claimed
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed
EP-1032556-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE WYETH CORP (US) 2007-12-19 EP disclosed